Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems.

Autor: Tavares Luiz M; School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Ribeirão Preto, SP, Brazil., Santos Rosa Viegas J; School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Ribeirão Preto, SP, Brazil., Palma Abriata J; School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Ribeirão Preto, SP, Brazil., Viegas F; Department of Computer Science, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil., Testa Moura de Carvalho Vicentini F; School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Ribeirão Preto, SP, Brazil., Lopes Badra Bentley MV; School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Ribeirão Preto, SP, Brazil., Chorilli M; School of Pharmaceutical Sciences, Sao Paulo State University, Araraquara, SP, Brazil., Maldonado Marchetti J; School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Ribeirão Preto, SP, Brazil., Tapia-Blácido DR; Department of Chemistry, Faculty of Philosophy, Sciences and Letters of Ribeirao Preto, University of São Paulo, Ribeirao Preto, SP, Brazil.
Jazyk: angličtina
Zdroj: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2021 Aug; Vol. 165, pp. 127-148. Date of Electronic Publication: 2021 May 13.
DOI: 10.1016/j.ejpb.2021.05.011
Abstrakt: Nanotechnology has been widely applied to develop drug delivery systems to improve therapeutic performance. The effectiveness of these systems is intrinsically related to their physicochemical properties, so their biological responses are highly susceptible to factors such as the type and quantity of each material that is employed in their synthesis and to the method that is used to produce them. In this context, quality-oriented manufacturing of nanoparticles has been an important strategy to understand and to optimize the factors involved in their production. For this purpose, Design of Experiment (DoE) tools have been applied to obtain enough knowledge about the process and hence achieve high-quality products. This review aims to set up the bases to implement DoE as a strategy to improve the manufacture of nanocarriers and to discuss the main factors involved in the production of the most common nanocarriers employed in the pharmaceutical field.
(Copyright © 2021 Elsevier B.V. All rights reserved.)
Databáze: MEDLINE